iTrack™ Canaloplasty to be Featured in 31 Presentations in the Official 2024 ASCRS Annual Meeting
Media Release General iTrack Molteno3 AlphaRET
22 Mar, 2024
iTrack™ Canaloplasty to be Featured at the 2024 American Glaucoma Society (AGS) Annual Meeting
Media Release General iTrack Molteno3 AlphaRET
23 Jan, 2024
iTrack™ Advance Real-World Registry Data and CATALYST Study Data to be Presented at the 2023 ESCRS Annual Congress, Vienna
Media Release General iTrack Molteno3 AlphaRET
1 Sept, 2023
iTrack™ Canaloplasty to be Featured at the Congress of German Ophthalmic Surgery (DOC) 2023
Media Release General iTrack Molteno3 AlphaRET
15 June, 2023
Nova Eye Medical Launches Next Generation Canaloplasty Device for Glaucoma, iTrack™ Advance
Media Release General iTrack
19 Apr, 2022
iTrack™ Canaloplasty to be Featured at the 2022 ASCRS Annual Meeting
Media Release General iTrack
12 Apr, 2022
Nova Eye, Inc., President Appointed to American Glaucoma Society (AGS) Foundation Advisory Board
Media Release General iTrack
31 Mar, 2022
One Year Evaluation of Endothelial Cell Density Following iTrack™ to be Spotlighted at ESCRS 2021
Media Release General iTrack
8 Oct, 2021
5-Year Effectiveness and Safety Data for iTrack™ to be Spotlighted at ESCRS 2021
Media Release General iTrack
8 Oct, 2021
Long-Term Effectiveness of iTrack™ MIGS Procedure to be Spotlighted at 2021 Swiss Society of Ophthalmology
Media Release General iTrack
25 Aug, 2021
2RT® Featured at the 2021 Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
Media Release General AlphaRET
3 May, 2021
Nova Eye Medical Announces First Patient Enrolled in “MAGIC” Multi-Center Canaloplasty Trial for Glaucoma
Media Release General iTrack
30 Apr, 2021
24-Month iTrack™ Data Demonstrate Real-World Efficacy of Canaloplasty as Standalone and Combined MIGS Procedure
Media Release General iTrack
20 Apr, 2021
Positive Five-Year Post-LEAD Trial Results for 2RT®
Media Release General AlphaRET
5 Mar, 2021
iTrack™ MIGS Procedure to Feature at the American Glaucoma Society (AGS) 2021 Virtual Meeting
Media Release General iTrack
4 Mar, 2021
Prospective Multi-Center Trial to Compare Efficacy and Safety Outcomes of Ab-Interno Canaloplasty for Glaucoma
Media Release General iTrack
2 Mar, 2021
iTrack™ to Feature at Australian and New Zealand Glaucoma Society (ANZGS) 2021 Meeting
Media Release General iTrack
19 Feb, 2021
iTrack™ Under Assessment for Public Funding via Australian Government’s Medical Benefit Scheme
Media Release General iTrack
18 Feb, 2021
iTrack™ MIGS Procedure Under Assessment for Public Funding via the Australian Government’s Medical Benefit Scheme
Media Release General iTrack
18 Feb, 2021
iTrack™ and Molteno3® Glaucoma Technologies to Feature at the AAO 2020 Virtual Meeting
Media Release iTrack Molteno3
13 Nov, 2020
Multicenter Study Highlights Surgical Efficiency of the Molteno3® Glaucoma Drainage Device
Media Release Molteno3
5 Aug, 2020
Nova Eye Medical Acquires Molteno3 Glaucoma Drainage Device Portfolio
Media Release Molteno3
6 July, 2020
For media enquires please contact:
Kate Hunt
Nova Eye Medical Limited
W +61 404 080 679
khunt@nova-eye.com